Morgan Stanley (MS-PF) Research & Development (2009 - 2026)

Morgan Stanley (MS-PF) has 18 years of Research & Development data on file, last reported at $1.1 billion in Q1 2026.

• Research & Development for Q1 2026 came in at $1.1 billion, up 9.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.5 billion (up 8.51% YoY), and the FY2025 annual result was $4.4 billion, up 8.07% from the prior year.
• Research & Development declined to $1.1 billion in Q1 2026 per MS-PF's latest filing, from $1.2 billion in the prior quarter.
• Over five years, Research & Development peaked at $1.2 billion in Q4 2025 and troughed at $829.0 million in Q1 2022.
• A 5-year average of $995.4 million and a median of $987.0 million in 2023 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2023: Research & Development rose 13.1% in 2022, then increased 5.79% in 2023.
• A 5-year view of Research & Development shows it stood at $933.0 million in 2022, then rose by 5.79% to $987.0 million in 2023, then gained by 7.29% to $1.1 billion in 2024, then advanced by 9.54% to $1.2 billion in 2025, then retreated by 1.03% to $1.1 billion in 2026.
• Business Quant data shows MS-PF's Research & Development at $1.1 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.1 billion in Q3 2025.